NCT01208155View on ClinicalTrials.gov

Study in Healthy Males to Assess Bioavailability of 4 Different Fostamatinib Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
BioavailabilityPharmacokinetics
Interventions
DRUG

Fostamatinib

Oral tablets, 50 mg x 2, single dose

DRUG

Fostamatinib

Oral tablets, 100 mg Batch 1, single dose

DRUG

Fostamatinib

Oral tablets, 100 mg Batch 2, single dose

DRUG

Fostamatinib

Oral tablets, 100 mg Batch 3, single dose

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY